XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock (Class A, B and Exchangeable)
Additional Paid-in-Capital
Accumulated Deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2023   234,270,384      
Beginning balance at Dec. 31, 2023 $ 463,436 $ 2 $ 1,431,056 $ (967,622) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (284,755)     (284,755)  
Other comprehensive income (loss) 0        
Stock option exercises and other (in shares)   7,827,268      
Stock option exercises and other 5,586   5,586    
Stock-based compensation 50,904   50,904    
Common stock sales issuances, net of issuance costs (in shares)   44,026,627      
Common stock sales issuances, net of issuance costs 289,388 $ 1 289,387    
Ending balance (in shares) at Sep. 30, 2024   286,124,279      
Ending balance at Sep. 30, 2024 524,559 $ 3 1,776,933 (1,252,377) 0
Beginning balance (in shares) at Jun. 30, 2024   280,968,276      
Beginning balance at Jun. 30, 2024 584,449 $ 3 1,740,981 (1,156,535) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (95,842)     (95,842)  
Other comprehensive income (loss) 0        
Stock option exercises and other (in shares)   2,689,679      
Stock option exercises and other 732   732    
Stock-based compensation 18,252   18,252    
Common stock sales issuances, net of issuance costs (in shares)   2,466,324      
Common stock sales issuances, net of issuance costs 16,968   16,968    
Ending balance (in shares) at Sep. 30, 2024   286,124,279      
Ending balance at Sep. 30, 2024 $ 524,559 $ 3 1,776,933 (1,252,377) 0
Beginning balance (in shares) at Dec. 31, 2024 396,802,394 396,802,394      
Beginning balance at Dec. 31, 2024 $ 1,034,782 $ 4 2,473,698 (1,431,283) (7,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (536,637)     (536,637)  
Other comprehensive income (loss) 41,730       41,730
Stock option exercises and other (in shares)   11,645,465      
Stock option exercises and other 3,813   3,772 41  
Stock-based compensation 87,460   87,460    
Common stock sales issuances, net of issuance costs (in shares)   79,497,667      
Common stock sales issuances, net of issuance costs 395,485 $ 1 395,484    
Class A shares issued for asset acquisition (in shares)   3,854,975      
Class A shares issued for asset acquisition $ 20,315   20,315    
Ending balance (in shares) at Sep. 30, 2025 491,800,501 491,800,501      
Ending balance at Sep. 30, 2025 $ 1,046,948 $ 5 2,980,729 (1,967,879) 34,093
Beginning balance (in shares) at Jun. 30, 2025   432,830,642      
Beginning balance at Jun. 30, 2025 919,146 $ 4 2,681,111 (1,805,589) 43,620
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (162,253)     (162,253)  
Other comprehensive income (loss) (9,527)       (9,527)
Stock option exercises and other (in shares)   2,871,306      
Stock option exercises and other (438)   (401) (37)  
Stock-based compensation 25,244   25,244    
Common stock sales issuances, net of issuance costs (in shares)   52,243,578      
Common stock sales issuances, net of issuance costs 254,461 $ 1 254,460    
Class A shares issued for asset acquisition (in shares)   3,854,975      
Class A shares issued for asset acquisition $ 20,315   20,315    
Ending balance (in shares) at Sep. 30, 2025 491,800,501 491,800,501      
Ending balance at Sep. 30, 2025 $ 1,046,948 $ 5 $ 2,980,729 $ (1,967,879) $ 34,093